Cocrystal-enabled bilayer fixed-dose combination of empagliflozin and metformin: from solid-state design to clinical bioequivalence

Journal of Pharmaceutical Investigation · Published 2026-07-27 · DOI 10.1007/s40005-026-00822-5

Authors (7)

Su Kyoung Lee, Jun Ki Kim, Ji Hye Park, Jeong Hoon Seo, Jae Taek Hwang, Eun Ji Noh, Eun Hee Lee

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lee, S., Kim, J., Park, J., et al. (2026). Cocrystal-enabled bilayer fixed-dose combination of empagliflozin and metformin: from solid-state design to clinical bioequivalence. Journal of Pharmaceutical Investigation. https://doi.org/10.1007/s40005-026-00822-5

Related articles

• Dose optimization of omadacycline for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) using a physiologically based pharmacokinetic modeling approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Architecture-driven optimization of nanocarriers for pH-responsive drug delivery · Journal of Pharmaceutical Investigation · 2026 · Same journal
• From meal to medicine: exploring the roots and consequences of drug-food effects · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Antimicrobial and thermostabilizing properties of a novel surfactant on different bacterial species · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Mechanistic insights into the self-assembly and cellular uptake of thermoresponsive pNIPAM-grafted hyaluronic acid nanogels · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Exploring anti-integrin α6 antibody and transferrin-decorated dual drug-loaded liposomes as a promising nanoplatform for glioblastoma therapy: a preclinical approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Necessity of considering sex factors in the clinical application of transdermal formulations · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Immune-chemo combination therapy using doxorubicin/viral epitope Pluronic nanoparticles · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Unveiling the treatment potential of irinotecan-loaded biopolymeric nanocarrier system in skin cancer via targeting CD44 receptors · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Advances in pharmaceutical formulation technologies for thermostable vaccine platforms considering patient-centered design · Journal of Pharmaceutical Investigation · 2025 · Same journal